Kailera Therapeutics, Inc. Financials
KLRA
All currency values in $ millions unless otherwise noted
| Income Statement | DEC 2025 |
|---|---|
| Revenues | |
| Revenue | $0 |
| Operating Income | -$158 |
| Net Income | |
| Net Income | -$149 |
Peers
Biotechnology · Pick stocks to compare with KLRA
CompareIntrinsic value
Held by ETFs
KLRA is in 9 US ETFs. The largest of them, with KLRA's weight in each:
Vanguard Small-Cap Growth ETFVBK0.01%of the fund
iShares Russell 2000 Growth ETFIWO0.03%of the fund
State Street SPDR S&P Biotech ETFXBI0.16%of the fund
Fidelity Blue Chip Growth ETFFBCG0.01%of the fund
Vanguard Russell 2000 Growth ETFVTWG0.02%of the fund
JPMorgan BetaBuilders U.S. Small Cap Equity ETFBBSC0.03%of the fund
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
5 of 5 free stocks used today
Keep analysing KLRA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.